Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeEXECUTIVESRobert DeRyke Named President and CEO of Terumo Cardiovascular Group: Effective April...

Robert DeRyke Named President and CEO of Terumo Cardiovascular Group: Effective April 1, 2017

April 7, 2017

Robert DeRyke has been appointed President and CEO of Terumo Cardiovascular (CV) Group effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter.

In this position, Robert DeRyke will lead Terumo’s global business related to the cardiopulmonary bypass market including Terumo Cardiovascular Systems (CVS), CV Group’s operating company in the United States.

Prior to this appointment, Robert DeRyke served as President of Terumo CV Group’s Electromechanical (EM) Systems Division. “Under his leadership, Rob brought stability and improved profitability to the business,” said Shinjiro Sato, President and CEO of Terumo Corporation, Terumo CV Group’s parent company.

DeRyke takes lead of a company with deep expertise in the cardiac arena, well positioned for the future.

“We have a strong foundation of talent, technologies, and systems to build on as we deliver long-term value to our customers and their patients,” said Robert DeRyke.

Terumo CV Group is building momentum that will create a positive impact for healthcare providers and the critically ill patients they serve.  Having recently cleared the shipping restrictions imposed as a condition of its 2011 consent decree, the company is preparing to return its flagship Terumo® Advanced Perfusion System 1 heart-lung machine to market in June 2017. As a market leader in oxygenators and cardiac monitoring technologies, Terumo CV Group will introduce its newest CAPIOX® oxygenator and CDI® inline blood gas monitoring system later this year, reinforcing the company’s commitment to the global cardiac community.

DeRyke joined Terumo in 2012 as Vice President of Corporate Quality for Terumo CVS. He has over 25 years’ experience in medical devices and pharmaceuticals, and has held executive leadership positions for Baxter Healthcare, Hospira, and Thermo-Fisher Scientific. He holds a Master of Business Administration from Michigan State University and a Bachelor of Science in Chemistry from Western Michigan University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy and liquefy tissue in the liver without incisions, ionizing radiation or heat.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy